// App-Quantinova.ai

243 : Long‐term risk of serious infections in patients with rheumatoid arthritis treated with rituximab: five year data from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR‐RA)

Researchers

Presenter

  • Diederik De Cock

Principal Investigators

  • Lianne Kearsley-Fleet

  • Lucia Silva-Fernandez

  • Mark Lunt

  • Kath Watson

  • Deborah Symmons

  • Kimme Hyrich

Medical Centers

  • Arthritis Research UK Centre for Epidemiology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved